Sort
64,565 grants matching “drug discovery”
Developmental and Translational Pharmacology of Pediatric Antimicrobial Therapy
$691,933Edmund Vincent Capparelli · University Of California, San Diego · U54 · FY2013 · HD
Preclinical optimization of a parasiticidal drug for cryptosporidiosis
$691,919Christopher D Huston · University Of Vermont & St Agric College · R01 · FY2019 · AI
High-throughput assays and small-molecule discovery of antiviral candidates targeting influenza hemagglutinin
$691,905Ian A Wilson · Scripps Research Institute, The · R01 · FY2024 · AI
Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy
$691,849Steven Terry Rosen · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA
Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy
$691,849Steven Terry Rosen · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA
Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy
$691,849Steven Terry Rosen · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
Development of small molecule inhibitor of Mcl-1 for cancer treatment
$691,769Michael H Cardone · Eutropics Pharmaceuticals, Inc. · R44 · FY2010 · CA
Contribution of Stress Induced Autonomic and Urothelial Dysregulation to IC/BPS
$691,717Lori A Birder · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · DK
Paul Calabresi Clinical Oncology Award
$691,698Robert C Bast · University Of Tx Md Anderson Can Ctr · K12 · FY2022 · CA
Development of a Next Generation Visual Performance Assessment System for Rodents
$691,652Xinmin Simon Xie · Afasci, Inc. · R44 · FY2020 · EY
Ubiquitin-independent targeted protein degradation
$691,634Lizbeth K. Hedstrom · Brandeis University · R01 · FY2024 · GM
Ubiquitin-independent targeted protein degradation
$691,634Lizbeth K. Hedstrom · Brandeis University · R01 · FY2023 · GM
Ubiquitin-independent targeted protein degradation
$691,634Lizbeth K. Hedstrom · Brandeis University · R01 · FY2022 · GM
Creation of in vivo active chemical probes for CAMKK2 to treat cancer
$691,617David Harold Drewry · Univ Of North Carolina Chapel Hill · R01 · FY2017 · CA
MWAS+ â A Novel Drug Repurposing Strategy for ADRD Prevention
$691,614Qing Zeng · George Washington University · R01 · FY2024 · AG
Genomic-wide Kinase Sequencing of Pediatric Brain Tumors
$691,465Thomas M Roberts · Dana-Farber Cancer Inst · R01 · FY2008 · CA
ETIOLOGY OF SUBSTANCE USE IN AUSTRALIA /USA
$691,310University Of Washington · R01 · FY2004 · DA
Core--Drug Screening and Chemistry Facility
$691,222Jeffrey W Smith · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2008 · AI
Does neurotransmitter plasticity of para-serotonergic neurons augment autoresuscitation following perinatal stress and buffer SIDS risk?
$691,218Susan M Dymecki · Harvard Medical School · R01 · FY2020 · HD
Phenotype MicroArrays for Drug Toxicity Screening
$691,208Barry Ronald Bochner · Biolog, Inc. · R44 · FY2007 · MH
Mechanisms of HIV fitness and drug resistance inferred from high-resolution molecular dynamics and sequence co-variation models
$691,081Ronald Levy · Temple Univ Of The Commonwealth · R01 · FY2023 · AI
Predictive Smoking Cessation Preclinical Battery
$691,074Taleen G Hanania · Psychogenics, Inc. · R44 · FY2014 · DA
Optimization of biliverdin IXβ reductase redox inhibitors as novel reagents for enhancing platelet production
$690,965Natasha M. Nesbitt · Blood Cell Technologies, Llc · R44 · FY2021 · HL
Genetic Epidemiology of Refractive Error
$690,923Dwight E Stambolian · University Of Pennsylvania · R01 · FY2011 · EY
Leukocyte Gene Expression and Genetic Biomarkers of OA Incidence and Progression
$690,808Steven B Abramson · New York University School Of Medicine · R01 · FY2016 · AR